Lipid-lowering treatment in peripheral artery disease
Highlights•Peripheral artery disease (PAD) is characterized by increased cardiovascular
risk.•Statins remain the first-line lipid-lowering therapy to treat PAD patients.•Statins …
risk.•Statins remain the first-line lipid-lowering therapy to treat PAD patients.•Statins …
Lipid-lowering treatment in peripheral artery disease
N Katsiki, AD Giannoukas, VG Athyros, DP Mikhailidis - 2018 - ir.lib.uth.gr
Peripheral artery disease (PAD) is characterized by increased cardiovascular (CV) risk, limb
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
Lipid-lowering treatment in peripheral artery disease.
N Katsiki, AD Giannoukas, VG Athyros… - Current Opinion in …, 2018 - europepmc.org
Peripheral artery disease (PAD) is characterized by increased cardiovascular (CV) risk, limb
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
Lipid-lowering treatment in peripheral artery disease
N Katsiki, AD Giannoukas… - Current opinion in …, 2018 - pubmed.ncbi.nlm.nih.gov
Peripheral artery disease (PAD) is characterized by increased cardiovascular (CV) risk, limb
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
morbidity and all-cause mortality. According to the current guidelines (2016) of the American …
[引用][C] Lipid-lowering treatment in peripheral artery disease
N Katsiki, AD Giannoukas, VG Athyros… - Current Opinion in …, 2018 - cir.nii.ac.jp